Abiopharma

New Form 8-K - Incannex Healthcare Inc. Filed: 2025-06-17 AccNo: 0001213900-25-054952 Size: 220 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form SC TO-T/A - Inozyme Pharma, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141753 Size: 24 KB

New Form 8-K - Verve Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141748 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Mineralys Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001933414-25-000070 Size: 223 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form SC 14D9 - Blueprint Medicines Corp Filed: 2025-06-17 AccNo: 0001193125-25-141740 Size: 815 KB

New Form 8-K - Dyne Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141739 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Aldeyra Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001213900-25-054949 Size: 218 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - PURPLE BIOTECH LTD. Filed: 2025-06-17 AccNo: 0001213900-25-054948 Size: 29 KB

New Form 6-K - KAMADA LTD Filed: 2025-06-17 AccNo: 0001213900-25-054947 Size: 22 KB

New Form 6-K - Haleon plc Filed: 2025-06-17 AccNo: 0001654954-25-007079 Size: 51 KB